Prognostic value of global myocardial flow reserve in patients with history of coronary artery bypass grafting

Author:

Al Rifai Mahmoud1,Ahmed Ahmed Ibrahim1ORCID,Saad Jean Michel1,Alahdab Fares1,Nabi Faisal1,Al-Mallah Mouaz H1

Affiliation:

1. Houston Methodist DeBakey Heart & Vascular Center , Houston, TX , USA

Abstract

Abstract Aims It is not well understood whether positron emission tomography (PET)-derived myocardial flow reserve (MFR) is prognostic among patients with prior coronary artery bypass grafting (CABG). Methods and results Consecutive patients with a clinical indication for PET were enrolled in the Houston Methodist DeBakey Heart and Vascular Center PET registry and followed prospectively for incident outcomes. The primary outcome was a composite of all-cause death, myocardial infarction (MI)/unplanned revascularization, and heart failure admissions. Cox proportional hazards models were used to study the association between MFR (<2 vs. ≥2) and incident events adjusting for clinical and myocardial perfusion imaging variables. The study population consisted of 836 patients with prior CABG; mean (SD) age 68 (10) years, 53% females, 79% Caucasian, 36% non-Hispanic, and 66% with MFR <2. Over a median (interquartile range [IQR]) follow-up time of 12 (4–24) months, there were 122 incident events (46 HF admissions, 28 all-cause deaths, 23 MI, 22 PCI/3 repeat CABG 90 days after imaging). In adjusted analyses, patients with impaired MFR had a higher risk of the primary outcome [hazard ratio (HR) 2.06; 95% CI 1.23–3.44]. Results were significant for admission for heart failure admissions (HR 2.92; 95% CI 1.11–7.67) but not for all-cause death (HR 2.01, 95% CI 0.85–4.79), or MI/UR (HR 1.93, 95% CI 0.92–4.05). Conclusion Among patients with a history of CABG, PET-derived global MFR <2 may identify those with a high risk of subsequent cardiovascular events, especially heart failure, independent of cardiovascular risk factors and perfusion data.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Reassessing the Role of Ischemia Imaging: Insights from the ISCHEMIA Trial;Nuclear Medicine and Molecular Imaging;2024-01-09

2. Cardiovascular imaging research and innovation in 2023;European Heart Journal - Imaging Methods and Practice;2024-01

3. Significance of myocardial flow reserve after revascularization;European Heart Journal - Cardiovascular Imaging;2023-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3